Search Count: 1
 |
Preclinical Characterization Of Azd3839, A Novel Clinical Candidate Bace1 Inhibitor For The Treatment Of Alzheimer Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-10-17 Classification: HYDROLASE Ligands: ACT, NA, 32D |